<DOC>
	<DOCNO>NCT02005146</DOCNO>
	<brief_summary>Define patient lose HBsAg , study loss predictive factor suspension treatment , study evolution</brief_summary>
	<brief_title>Retrospective Observational Study Define HBsAg Loss With Without Seroconversion antiHBs Patients With Chronic Hepatitis B Virus Treated With Nucleoside/Nucleotide Analogs</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<criteria>&gt; 18 year old Chronic hepatitis B ( HBeAg+ HBeAg ) HBsAg loss Treated nucleoside/nucleotide analogue With without previous interferon ( IFN/PEGIFN ) Patients HBsAg loss 2006 Immunocompetent patient Spontaneous HBsAg loss HBsAg loss treatment monotherapy combinated IFN PEGIFN . Patients hepatitis delta virus ( HDV ) coinfection . Patients hepatitis C virus ( HCV ) coinfection . Patients HIV coinfection . Patients liver transplant . Patients reactivate hepatitis B virus ( HBV ) immunosuppressive treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Hepatitis B</keyword>
	<keyword>Nucleoside/nucleotide</keyword>
	<keyword>HBsAg loss</keyword>
</DOC>